DIAGNOSTIC TEST PANEL 527
Systemic Sclerosis/Scleroderma – Extended Analysis
Diagnostic test panel for antibodies against RNA polymerase, fibrillarin, PM/Scl, and Th/To. For suspicion of Systemic Sclerosis/Scleroderma.
Indication
In-depth analysis is ordered when diagnosis has been established or if there is a strong suspicion of scleroderma/systemic sclerosis and when it is desired to differentiate between sub-entities. As shown in the investigation algorithm below, the analysis may be extended with a determination of antibodies against PM-Scl (p100), Th/To, RNA polymerase, and Fibrillarin.
Clinical background
It is a disease with an unclear etiology, which affects many organ systems, mainly the skin and the blood vessels. Still, the lungs and the gastrointestinal tract may also be affected. Kidney, heart, and muscle symptoms are less common. The most common clinical characteristics are dermatofibrosis of varying intensity and extent and circulation disorders in fingers and toes (Raynaud’s phenomenon). The disease is usually divided into different forms, such as:
- Limited form (usually in the face and distally toward the elbow and knee) fits in with CREST syndrome.
- Diffuse forms of skin symptoms, proximally to the elbow and on the body.
- Overlap syndrome.
- Serological investigation
Tests included in panel
Need pricing information?
How to order
This test panel is available worldwide for hospitals, clinics, and physicians.
-
Print and complete the request form
Download the request form. Clearly state the name and phone number of the referring hospital, clinic, or physician. -
Prepare your samples
Serum: At least 0.5 mL serum (plain serum tubes without additives).
-
Send samples and request form
Within Sweden
Samples can be sent at room temperature to:
Envelopes and smaller boxes:
Wieslab AB, Box 50117, 20211 Malmö, Sweden
Larger boxes and frozen samples:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
International
Samples can be sent at room temperature to:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
Last updated: 2025-08-18